Fiscal Year 2021「Medical and Engineering Collaboration Innovation Promotion Project (Development and Commercialization Project)」About the selected projects

We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and…

We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…

As of December 13, 2023, our company name has changed from E.P.Medical Inc. to Epsilon Medical Inc. We appreciate your…